Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age

Journal of Infectious Diseases

Volumn 211, Issue 1, 2015, Pages 100-108

  Banister, Carolyn E ^a   Messersmith, Amy R ^a,e,f   Cai, Bo ^b   Spiryda, Lisa B ^b,e,f   Glover, Saundra H ^b,c   Pirisi, Lucia ^d   Creek, Kim E ^a  

^a Department of Biomedical and Pharmaceutical Sciences   (United States)

^b Department of Epidemiology and Biostatistics ^*  (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e PRESBYTERIAN COLLEGE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

health disparities; HPV; HPV persistence; human papillomavirus; viral clearance.

Indexed keywords

WART VIRUS VACCINE; VIRUS DNA;

ADULT; AFRICAN AMERICAN; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INCIDENCE; INFECTION RATE; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PROSPECTIVE STUDY; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRAL CLEARANCE; YOUNG ADULT; ADOLESCENT; CAUCASIAN; ETHNOLOGY; GENETICS; HEALTH DISPARITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTOR; SOUTH CAROLINA; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADOLESCENT; AFRICAN AMERICANS; COHORT STUDIES; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SOUTH CAROLINA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84922456145     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu394     Document Type: Conference Paper

References (49)

1. Walboomers JM, Marcel VJ, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
2. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-8.
3. Dalstein V, Riethmuller D, Prtet J-L, et al. Persistence and load of highrisk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 2003; 106:396-403.
4. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286:3106-14.
5. American Cancer Society. Cancer facts & figures 2013. Atlanta: American Cancer Society 2013.
6. Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM Jr, Chuba PJ, Schwartz K. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol 2005; 97:550-8.
7. Adams SA, Fleming A, Brandt HM, et al. Racial disparities in cervical cancer mortality in an African American and European American cohort in South Carolina. J S C Med Assoc 2009; 105:237-44.
8. Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol 2008; 109: S22-30.
9. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer 2007; 109:348-58.
10. Movva S, Noone AM, Banerjee M, et al. Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer 2008; 112:1264-71.
11. Brandt HM, Modayil MV, Hurley D, et al. Cervical cancer disparities in South Carolina: an update of early detection, special programs, descriptive epidemiology, and emerging directions. J S C Med Assoc 2006; 102:223-30.
12. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813-9.
13. Banister C, Messersmith A, Chakraborty H, et al. HPV prevalence at enrollment and baseline results from the Carolina Womens Care Study, a longitudinal study of HPV persistence in women of college age. Inter J Womens Health 2013; 2013:379-88.
14. Pan W. Extending the iterative convex minorant algorithm to the Cox model for interval-censored data. J Comput Graph Stat 1999; 78: 109-20.
15. Henschel V, Mansmann U, Heiss C. intcox: compendium to apply the iterative convex minorant algorithm to interval censored event data, 2009. http://cran.r-project.org/web/packages/intcox/index.html. Accessed 1 August 2014.
16. Team RDC. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2007.
17. Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmt) 2012; 21:1031-7.
18. Simard EP, Naishadham D, Saslow D, Jemal A. Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol 2012; 127:611-5.
19. Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007; 31:157-81.
20. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidem Biomar 2003; 12:485-90.
21. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-26.
22. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357:1831-6.
23. Ragin CC, Watt A, Markovic N, et al. Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer 2009; 4(suppl 1):S9.
24. Manhart LE, Holmes KK, Koutsky LA, et al. Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sex Transm Dis 2006; 33:502-8.
25. Seth P, Wingood GM, Robinson LS, Diclemente RJ. Exposure to highrisk genital human papillomavirus and its association with risky sexual practices and laboratory-confirmed chlamydia among African-American women. Womens Health Iss 2009; 19:344-51.
26. Vidal AC, Smith JS, Valea F, et al. HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. Cancer Cause Control 2014; 25:1055-62.
27. Niccolai LM, Russ C, Julian PJ, et al. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty. Cancer 2013; 119:3052-8.
28. Chen HC, Schiffman M, Lin CY, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 2011; 103:1387-96.
29. Sundstrom K, Eloranta S, Sparen P, et al. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix. Cancer Epidem Biomar 2010; 19:2469-78.
30. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Womens Health Study. J Infect Dis 2002; 186:462-9.
31. Goodman MT, Shvetsov YB, McDuffie K, et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008; 68:8813-24.
32. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004; 57:68-72.
33. Schmitt M, Depuydt C, Benoy I, et al. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol 2013; 51:1458-64.
34. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidem Biomar 2006; 15:1274-80.
35. Dal Bello B, Spinillo A, Alberizzi P, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 2009; 81:703-12.
36. Smith B, Chen Z, Reimers L, et al. Sequence imputation of HPV16 genomes for genetic association studies. PLoS One 2011; 6:e21375.
37. Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 2011; 17:132-44.
38. Magnusson PK, Sparen P, Gyllensten UB. Genetic link to cervical tumours. Nature 1999; 400:29-30.
39. Hibma MH. The immune response to papillomavirus during infection persistence and regression. Open Virol J 2012; 6:241-8.
40. Bernal-Silva S, Granados J, Gorodezky C, et al. HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study. Infect Agent Cancer 2013; 8:31.
41. Ferguson R, Ramanakumar AV, Richardson H, et al. Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol 2011; 72:337-41.
42. Einstein MH, Leanza S, Chiu LG, et al. Genetic variants in TAP are associated with high-grade cervical neoplasia. Clin Cancer Res 2009; 15:1019-23.
43. Oliveira LB, Louvanto K, Ramanakumar AV, Franco EL, Villa LL. Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection. J Gen Virol 2013; 94:1858-64.
44. Torres-Poveda K, Burguete-Garcia AI, Cruz M, et al. The SNP at -592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development. Infect Agent Cancer 2012; 7:32.
45. Rosa MI, Moraes MV, Vuolo F, et al. Association of interleukin-6 in women with persistence of DNA-HPV: a nested case-control study. Arch Gynecol Obstet 2011; 285:143-8.
46. Nunobiki O, Ueda M, Toji E, et al. Genetic polymorphism of cancer susceptibility genes and HPV infection in cervical carcinogenesis. Patholog Res Int 2011; 2011:364069.
47. Safaeian M, Hildesheim A, Gonzalez P, et al. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS One 2012; 7:e33619.
48. Nye MD, Hoyo C, Huang Z, et al. Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer. PLoS One 2013; 8:e56325.
49. Mirabello L, Schiffman M, Ghosh A, et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer 2013; 132:1412-22.